Literature DB >> 18347873

Esophageal cancers with synchronous or antecedent head and neck cancers: a more formidable challenge?

Oswens Siu-Hung Lo1, Simon Law, William I Wei, Wai-Man Ng, Kam-Ho Wong, King-Hung Tong, John Wong.   

Abstract

BACKGROUND: The presence of synchronous or antecedent head and neck cancers may complicate management of patients with primary esophageal cancer.
METHODS: From January 1982 to December 2004, by means of a prospectively collected database, we compared information from 119 patients with esophageal cancers who had synchronous or antecedent head and neck cancers with information from 1555 patients who only had squamous cell esophageal cancer in a tertiary referral academic hospital.
RESULTS: There were far more men and younger patients in those who had head and neck cancers, and multicentric tumors were also more common. Hypopharyngeal tumors were the most frequently encountered head and neck cancer and were found in 36.1% of patients. Resection rates of the primary esophageal cancers were similar in those who had head and neck cancers and in those who only had esophageal cancer (60.7% vs. 61.7% P = .74). Overall postoperative complication rates were not different. Thirty-day mortality rates were 0% and 2.9% for those who did and did not have head and neck tumors, respectively (P = .25). The respective hospital mortality rates were 10.3% and 9.5% (P = .83). Median survival for resectable esophageal cancers was 9.2 months for the former group and 13.4 months for the latter (P = .02).
CONCLUSIONS: Esophagectomy rates did not differ when synchronous or antecedent head and neck cancers were present. Similar postoperative morbidity and mortality rates could be achieved. The presence of additional head and neck tumors imparted a worse long-term prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 18347873     DOI: 10.1245/s10434-008-9860-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  Total neopharyngeal stenosis following pharyngolaryngo-oesophagectomy with gastric interposition: Successful recanalisation using a transcervical radiologically guided technique.

Authors:  Mark D Wilkie; Iain F Hathorn; Andrew S Evans
Journal:  Int J Surg Case Rep       Date:  2011-10-06

2.  Multiple primary malignant tumors of upper gastrointestinal tract: a novel role of 18F-FDG PET/CT.

Authors:  Long Sun; Ying Wan; Qin Lin; Yong-Hong Sun; Long Zhao; Zuo-Ming Luo; Hua Wu
Journal:  World J Gastroenterol       Date:  2010-08-21       Impact factor: 5.742

3.  Allogeneic transplantation of epidermal cell sheets followed by endoscopic submucosal dissection to prevent severe esophageal stricture in a porcine model.

Authors:  Shinichiro Kobayashi; Nobuo Kanai; Masayuki Yamato; Susumu Eguchi
Journal:  Regen Ther       Date:  2022-07-09       Impact factor: 3.651

4.  Clonal relationship and alcohol consumption-associated mutational signature in synchronous hypopharyngeal tumours and oesophageal squamous cell carcinoma.

Authors:  Josephine Mun-Yee Ko; Chen Guo; Conghui Liu; Lvwen Ning; Wei Dai; Lihua Tao; Anthony Wing-Ip Lo; Carissa Wing-Yan Wong; Ian Yu-Hong Wong; Fion Siu-Yin Chan; Claudia Lai-Yin Wong; Kwan Kit Chan; Tsz Ting Law; Nikki Pui-Yue Lee; Zhichao Liu; Haoyao Jiang; Zhigang Li; Simon Law; Maria Li Lung
Journal:  Br J Cancer       Date:  2022-10-19       Impact factor: 9.075

Review 5.  Surgical strategies for esophageal cancer associated with head and neck cancer.

Authors:  Masaru Morita; Hiroshi Saeki; Shuhei Ito; Yasue Kimura; Nami Yamashita; Koji Ando; Yukiharu Hiyoshi; Eriko Tokunaga; Eiji Oki; Tetsuo Ikeda; Sei Yoshida; Torahiko Nakashima; Yoshihiko Maehara
Journal:  Surg Today       Date:  2013-08-30       Impact factor: 2.549

6.  Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chih-Yen Chien; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Yan-Ye Su; Li-Hsueh Shih; Shau-Hsuan Li
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

7.  Chemoradiotherapy for Synchronous Multiple Primary Cancers with Esophageal Squamous Cell Carcinoma: a Case-control Study.

Authors:  Qi-Wen Li; Yu-Jia Zhu; Wen-Wen Zhang; Han Yang; Yao Liang; Yong-Hong Hu; Bo Qiu; Meng-Zhong Liu; Hui Liu
Journal:  J Cancer       Date:  2017-02-11       Impact factor: 4.207

8.  Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chih-Yen Chien; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Shau-Hsuan Li
Journal:  J Clin Med       Date:  2020-01-10       Impact factor: 4.241

9.  Screening for head and neck tumors in patients with esophageal squamous cell carcinoma and vice versa: a nationwide survey among medical specialists.

Authors:  Laurelle van Tilburg; Sophie A van den Ban; Steffi E M van de Ven; Aniel Sewnaik; Marco J Bruno; Manon C W Spaander; Robert J Baatenburg de Jong; Arjun D Koch
Journal:  Endosc Int Open       Date:  2022-09-14

10.  Screening for head and neck second primary tumors in patients with esophageal squamous cell cancer: A systematic review and meta-analysis.

Authors:  Sem van de Ven; O Bugter; J A Hardillo; M J Bruno; R J Baatenburg de Jong; A D Koch
Journal:  United European Gastroenterol J       Date:  2019-06-05       Impact factor: 4.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.